Valuation: Allied Corp.

Market Cap 1.3M 1.14M 1.05M 969K 1.83M 126M 1.87M 12.57M 4.94M 61.49M 4.9M 4.79M 212M P/E 2023
-2.13x
P/E 2024 -2.52x
Enterprise Value 7.55M 6.6M 6.09M 5.61M 10.58M 727M 10.81M 72.78M 28.63M 356M 28.36M 27.74M 1.23B EV / Sales 2023
394,366,816x
EV / Sales 2024 171,944,593x
Free-Float
100%
Yield 2023 *
-
Yield 2024 -
Current year 0
Extreme 0
0.01
1 year 0
Extreme 0
0.01
3 years 0
Extreme 0
0.26
5 years 0
Extreme 0
2.15
10 years 0
Extreme 0
4.5
Manager TitleAgeSince
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer 71 -
Corporate Officer/Principal - 02/05/2020
Director TitleAgeSince
Director/Board Member - 02/05/2020
Director/Board Member - -
Director/Board Member - 21/10/2024
Date Insider Type Main position Quantity % Market Cap.
25/04/23 Buy

Director

80,000 0.0824%
22/09/20 Buy

Chief Executive Officer

10,000 0.0118%
22/09/20 Other

Chief Executive Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 117
+0.15%-2.67%+217.39%-9.88% 2.47B
+4.52%+1.97%+113.30%+100.41% 1.62B
+0.22%-2.49%-24.97%+108.03% 450M
0.00%-1.69%+7.41%-3.33% 63.08M
Average +0.98%-2.42%+78.28%+48.81% 920.96M
Weighted average by Cap. +1.69%-2.17%+154.26%+40.47%

Financials

2023 2024
Net sales 0.07 0.06 0.06 0.05 0.1 6.94 0.1 0.69 0.27 3.4 0.27 0.26 11.71 0.1 0.08 0.08 0.07 0.13 9.26 0.14 0.93 0.36 4.54 0.36 0.35 15.62
Net income -10.68M -9.33M -8.61M -7.94M -14.96M -1.03B -15.29M -103M -40.47M -504M -40.09M -39.21M -1.73B -3.98M -3.47M -3.21M -2.96M -5.57M -383M -5.69M -38.33M -15.07M -188M -14.93M -14.6M -646M
Net Debt 5.65M 4.94M 4.56M 4.2M 7.92M 544M 8.09M 54.48M 21.43M 267M 21.23M 20.76M 918M 6.25M 5.46M 5.04M 4.64M 8.75M 602M 8.95M 60.22M 23.68M 295M 23.46M 22.95M 1.01B
Logo Allied Corp.
Allied Corp. is an international medical cannabis production company. The Company is engaged in researching, creating, and producing targeted cannabinoid health solutions. It focuses on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder (PTSD), Parkinson’s disease, Tourette’s syndrome, irritable bowel syndrome (IBS) and spasticity associated with multiple sclerosis (MS) and spinal cord injury (SCI). Its core hemp-derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. The Tactical Relief brand's flagship product is a hemp-derived CBD tincture for sale in the United States. The Equilibrium Bio brand is primarily focused on hydration and recovery areas. The MaXXa brand develops natural CBD-infused cosmetics and beauty products.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. ALID Stock